3-(4-fluoro-5-methoxy-1H-indol-3-yl)-1-[2-(2-hydroxy-2-methylpropyl)-4,6-dimethylpiperidin-1-yl]-3-methylbutan-1-one
C25H37FN2O3 — CID 129115303
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(4-fluoro-5-methoxy-1H-indol-3-yl)-1-[2-(2-hydroxy-2-methylpropyl)-4,6-dimethylpiperidin-1-yl]-3-methylbutan-1-one
3-(4-fluoro-5-methoxy-1H-indol-3-yl)-1-[2-(2-hydroxy-2-methylpropyl)-4,6-dimethylpiperidin-1-yl]-3-methylbutan-1-one (PubChem CID 129115303) has the molecular formula C25H37FN2O3 and a molecular weight of 432.58 g/mol. Its IUPAC name is 3-(4-fluoro-5-methoxy-1H-indol-3-yl)-1-[2-(2-hydroxy-2-methylpropyl)-4,6-dimethylpiperidin-1-yl]-3-methylbutan-1-one.
Molecular Properties
| Compound Name | 3-(4-fluoro-5-methoxy-1H-indol-3-yl)-1-[2-(2-hydroxy-2-methylpropyl)-4,6-dimethylpiperidin-1-yl]-3-methylbutan-1-one |
|---|---|
| PubChem CID | 129115303 |
| Molecular Formula | C25H37FN2O3 |
| Molecular Weight | 432.58 g/mol |
| Exact Mass | 432.28 |
| IUPAC Name | 3-(4-fluoro-5-methoxy-1H-indol-3-yl)-1-[2-(2-hydroxy-2-methylpropyl)-4,6-dimethylpiperidin-1-yl]-3-methylbutan-1-one |
| SMILES | COc1ccc2[nH]cc(C(C)(C)CC(=O)N3C(C)CC(C)CC3CC(C)(C)O)c2c1F |
| InChI | InChI=1S/C25H37FN2O3/c1-15-10-16(2)28(17(11-15)12-25(5,6)30)21(29)13-24(3,4)18-14-27-19-8-9-20(31-7)23(26)22(18)19/h8-9,14-17,27,30H,10-13H2,1-7H3 |
| InChIKey | XDEBAQVRMOYTCT-UHFFFAOYSA-N |
| XLogP | 5.16 |
| TPSA | 65.56 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 432.58 |
| LogP ≤ 5 | 5.16 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 129115303 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.